IL6 and periodontal disorder: On one hand, periodontal disease triggers the release of inflammatory cytokines, such as interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α), which impair insulin signaling pathways, resulting in increased insulin resistance and poor glycemic control in diabetic patients [20].